Anja Smith, Stellenbosch University
South Africa has extremely high maternal mortality levels. This is true when compared with developed countries as well as other developing countries.
According to the World Health Organisation, for every 100,000 live births in the country in 2015, 138 women died due to pregnancy and childbirth complications. In Sweden, fewer than five women die for every 100,000 live births. In Brazil, the estimate is 44 women for every 100,000 live births.
Continue reading Why Mothers Aren’t Accessing Antenatal Care Early in Their Pregnancies
For years researchers who study maternal morbidity and mortality have been stumped as to why rates continue to rise and why women of color are adversely affected despite education, health care, and socio-economic factors.
A new report and the first of its kind released in May, New York City 2008 – 2012: Severe Maternal Morbidity, shows the myriad reasons why women of color, especially low-income, Black non-Latina, women fare the worse with severe maternal morbidity (SMM). While most studies in the past across the country focus on maternal mortality, this report focused on maternal morbidity, the causes of maternal mortality.
Continue reading NYC Report Tackles Maternal Morbidity Rates
Jeffrey H. Cohen, The Ohio State University
The Syrian civil war has entered its fifth year with few signs of ending.
The fighting has forced more than 13.5 million Syrians to flee their homes. Most of the displaced have not left Syria, but have simply moved around the country in an attempt to get out of the way of the fighting.
But approximately 4.8 million others have traveled beyond their nation’s borders in a search for security.
In my book Cultures of Migration, I argue that mass migrations and refugee crises don’t simply happen. They have a history and a trajectory. That work has led me to ask: Who are the Syrian refugees? What made their migration happen?
Continue reading Where Have 4.8 Million Syrian Refugees Gone?
Thesla Palanee-Phillips, University of the Witwatersrand
The results of the two studies showing that a vaginal ring can help reduce the risk HIV infection among women is being hailed as an important HIV prevention breakthrough.
Launched four years ago, the two clinical trials, known as ASPIRE and The Ring Study, set out to determine how safe and effective the ring was in prevention of HIV infection in women. The ring, which is used for a month at a time, contains an antiretroviral drug called dapivirine that acts by blocking HIV from multiplying.
The studies enrolled close to 4500 women aged 18 to 45 in South Africa, Uganda, Malawi and Zimbabwe. Each study found that the ring helps reduce the risk of HIV infection in women. In ASPIRE, the ring reduced the risk of HIV infection by 27% overall. In The Ring Study, infections were reduced by 31% overall.
Continue reading Why a new vaginal ring could be a game-changer in HIV prevention